A study by an institute in Milan, Italy showed that 11.6 percent of volunteers who participated in a lung cancer screening trial had developed COVID-19 antibodies, months before the first confirmed case was reported in China. #COVID19
A study by an institute in Milan, Italy showed that 11.6 percent of volunteers who participated in a lung cancer screening trial had developed COVID-19 antibodies, months before the first confirmed case was reported in China. #COVID19